SEC Form 4 · accession 0001485003-16-000174
Sesen Bio, Inc. · SESN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen A Hurly
Officer — President and CEO · Director
Period of report
Sep 20, 2016
Accepted (ET)
Sep 22, 2016 · 4:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001485003
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 20, 2016 | A | 398,031 | — | A | 398,031 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF2 | $3.37 | Sep 20, 2016 | A | 350,000 | A | — | Sep 19, 2026 | Common Stock | 350,000 | 350,000 | D |
Explanation of responses
- F1The reporting person acquired 398,031 shares of issuer common stock in exchange for a 9.9175% interest in Viventia Bio Inc. pursuant to the issuer's purchase of all of the outstanding capital stock of Viventia Bio Inc. on September 20, 2016. Of the 398,031 shares issued to the reporting person in the transaction, 39,803 shares are currently being held in escrow and are subject to forfeiture during the 15-month period following the transaction to satisfy claims arising as a result of Viventia Bio Inc.'s or the reporting person's breach of any of its or his representations, warranties or covenants in the share purchase agreement.
- F225% of the shares subject to such option shall vest on the first anniversary of the date of grant of the option and an additional 6.25% of the shares underlying the option shall vest at the end of each successive three-month period thereafter until the fourth anniversary of the date of grant of the option.